| MeSH term | MeSH ID | Detail |
|---|---|---|
| Inflammation | D007249 | 119 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Tibial Fractures | D013978 | 4 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:27137142 | ||||
| pmid:25669623 | ||||
| pmid:24671522 | ||||
| pmid: | ||||
| Sun FF et al. | Preparation of two dinor-PGI2 metabolites from 6-keto-PGF1 alpha by Mycobacterium rhodochrous. | 1980 | Prostaglandins | pmid:6258195 |
| Falardeau P et al. | Quantitative analysis of two dinor urinary metabolites of prostaglandin I2. | 1981 | Anal. Biochem. | pmid:7030131 |
| Rosenkranz B et al. | Urinary and systemic metabolites of prostacyclin in the perfused rabbit kidney. | 1982 | Ren Physiol | pmid:6750728 |
| Falardeau P and Brash AR | Quantitation of two dinor metabolites of prostacyclin by GC-MS. | 1982 | Meth. Enzymol. | pmid:6752645 |
| Watson ML et al. | Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome. | 1983 | Lancet | pmid:6135873 |
| Fischer S et al. | Prostacyclin metabolism in adults and neonates. Urinary profiles of 6-ketoprostaglandin F1 alpha and 2,3-dinor-6-ketoprostaglandin F1 alpha studied by gas chromatography-mass spectrometry. | 1983 | Biochim. Biophys. Acta | pmid:6337642 |
| Falardeau P and Martineau A | In vivo production of prostaglandin I2 in Dahl salt-sensitive and salt-resistant rats. | 1983 Sep-Oct | Hypertension | pmid:6352480 |
| Fitzgerald DJ et al. | The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans. | 1984 | Circulation | pmid:6428771 |
| Liggins GC et al. | Prostacyclin and maternal lupus anticoagulant. | 1984 | Lancet | pmid:6140483 |
| FitzGerald GA et al. | Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. | 1984 | N. Engl. J. Med. | pmid:6231483 |
| Vesterqvist O and Gréen K | Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1 alpha and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs. | 1984 | Prostaglandins | pmid:6548317 |
| Oates JA et al. | Comparison of the effects of selective inhibition of thromboxane synthase with those of inhibition of the cyclooxygenase enzyme in man. | 1984 | Trans. Am. Clin. Climatol. Assoc. | pmid:6433527 |
| Watson ML et al. | Prostaglandins and kallikrein during volume expansion in normal man. | 1984 | Contrib Nephrol | pmid:6570094 |
| Martineau A et al. | Defective synthesis of vasodilator prostaglandins in the spontaneously hypertensive rat. | 1984 Mar-Apr | Hypertension | pmid:6373595 |
| Fischer C and Meese CO | Simultaneous determination of 6-oxo-prostaglandin F1 alpha and 2,3-dinor-6-oxo-prostaglandin F1 alpha in biological fluids by stable isotope dilution and negative ion chemical ionization mass spectrometry. | 1985 | Biomed. Mass Spectrom. | pmid:2931130 |
| Roy L et al. | Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man. | 1985 | Circulation | pmid:3882264 |
| Watson ML et al. | Urinary kallikrein and systemic prostacyclin synthesis during sodium chloride infusion in normal man. | 1985 | Clin. Sci. | pmid:3884237 |
| Goldberg MR et al. | Prostacyclin biosynthesis and platelet function in autonomic dysfunction. | 1985 | Neurology | pmid:3838109 |
| Falardeau P et al. | Urinary levels of 2,3-dinor-6-oxo-PGF1 alpha: a reliable index of the production of PGI2 in the spontaneously hypertensive rat. | 1985 | Prostaglandins | pmid:3890022 |
| Gréen K and Vesterqvist O | In vivo synthesis of thromboxane and prostacyclin in man in health and disease. Data from GC-MS measurements of major urinary metabolites. | 1986 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2949557 |
| Reilly IA et al. | Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. | 1986 | Circulation | pmid:2938849 |
| Reilly IA et al. | Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. | 1986 | Br Med J (Clin Res Ed) | pmid:3083991 |
| Fischer S et al. | Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites. | 1986 | Biochim. Biophys. Acta | pmid:3754157 |
| Reilly IA and FitzGerald GA | Eicosenoid biosynthesis and platelet function with advancing age. | 1986 | Thromb. Res. | pmid:3754355 |
| Rosenkranz B et al. | Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. | 1986 | Br J Clin Pharmacol | pmid:3083851 |
| Guarner F et al. | Increased synthesis of systemic prostacyclin in cirrhotic patients. | 1986 | Gastroenterology | pmid:3510938 |
| Vesterqvist O | Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS. | 1986 | Eur. J. Clin. Pharmacol. | pmid:3519239 |
| Kuehl PG et al. | Systemic production of prostacyclin and thromboxane A2 does not correlate with patency of the ductus arteriosus in very low birth weight infants. | 1986 | J. Pediatr. | pmid:3519915 |
| Henriksson P et al. | In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction. | 1986 | Br Heart J | pmid:3521690 |
| Watson ML et al. | Systemic synthesis of prostaglandin I2 following sustained infusion of angiotensin II in conscious dogs. | 1986 | Eur. J. Pharmacol. | pmid:3530786 |
| Fitzgerald DJ et al. | Platelet activation in unstable coronary disease. | 1986 | N. Engl. J. Med. | pmid:3531859 |
| Huang YS et al. | Effect of indomethacin treatment on prostaglandin excretion and tissue phospholipid fatty acid composition in rats bearing mammotropic pituitary tumor, MtT-F4. | 1986 | Prostaglandins Leukot Med | pmid:3532134 |
| Ylikorkala O et al. | Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants. | 1986 | J. Clin. Endocrinol. Metab. | pmid:3536979 |
| Casas J et al. | Determination of 2,3-dinor-6-ketoprostaglandin F1 alpha in urine samples by liquid chromatography and radioimmunoassay. | 1986 | J. Chromatogr. | pmid:3558562 |
| Knapp HR et al. | In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. | 1986 | N. Engl. J. Med. | pmid:3007982 |
| Edlund A et al. | Myocardial ischaemia triggers formation of thromboxane. | 1987 | Lancet | pmid:2887865 |
| Gréen K and Vesterqvist O | In vivo synthesis of thromboxane A2 and prostaglandin I2 in healthy and diseased individuals. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959096 |
| Neiman J et al. | Platelet function during acetaldehyde intoxication in healthy male volunteers. | 1987 | Alcohol Alcohol Suppl | pmid:3426736 |
| Hamm CW et al. | Biochemical evidence of platelet activation in patients with persistent unstable angina. | 1987 | J. Am. Coll. Cardiol. | pmid:3668113 |
| Nowak J et al. | Vascular effects of infused adenosine are not mediated by prostacyclin release in humans. | 1987 | Am. J. Physiol. | pmid:3548440 |
| Cibattoni G et al. | Effects of sulindac on renal and extrarenal eicosanoid synthesis. | 1987 | Clin. Pharmacol. Ther. | pmid:3549118 |
| Fitzgerald DJ et al. | Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. | 1987 | Circulation | pmid:3552297 |
| Vesterqvist O et al. | Thromboxane and prostacyclin formation in patients with deep vein thrombosis. | 1987 | Thromb. Res. | pmid:3554598 |
| Gréen K et al. | Deficient prostacyclin formation after acute myocardial infarction. | 1987 | Lancet | pmid:2883378 |
| Neiman J et al. | Urinary excretion of 2, 3-dinor-6-keto prostaglandin F1 alpha and platelet thromboxane formation during ethanol withdrawal in alcoholics. | 1987 | J. Clin. Pathol. | pmid:3584500 |
| Förstermann U and Feuerstein TJ | Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine. | 1987 | Clin. Sci. | pmid:3308287 |